Bone marrow transplantation for autoimmune diseases

Acta Haematologica

Volumn 99, Issue 3, 1998, Pages 116-132

  Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoimmune disease; Bone marrow transplantation; Stem cell disorder

Indexed keywords

ADOPTIVE TRANSFER; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BONE GRAFT; CHRONIC GLOMERULONEPHRITIS; CONFERENCE PAPER; CROHN DISEASE; EMBRYONAL TISSUE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; GRAVES DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STROMA CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THYMUS;

EID: 0031968664     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040826     Document Type: Conference Paper

References (67)

1. Theofilopoulos AR, Dixon FJ: M urine models of systemic lupus erythematosus. Adv Immunol 1985;37:269-358.
2. Denman AM, Russell AS, Denman EJ: Adoptive transfer of the diseases of New Zealand Black mice to normal mouse strains. Clin Exp Immunol 1969;5:567-595.
3. Morton JI, Siegel BV: Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sci USA 1974;71:2162-2165.
4. Akizuki M, Reeves JP, Steinberg AD: Expression of autoimmunity by NZB/NZW marrow. Clin Immunol Immunopathol 1978;10:247-250.
5. Eisenberg RA, Izui S, McConahey PJ, Hang L, Peters CJ, Theofilopoulos AN, Dixon FJ: Male determined accelerated autoimmune disease in BXSB mice: Transfer by bone marrow and spleen cells. J Immunol 1980;125:1032-1036.
6. Jyonouchi H, Kincade PW, Good RA, Fernandes GJ: Reciprocal transfer of abnormalities in clonable B lymphocytes and myeloid progenitors between NZB and DBA/2 mice. J Immunol 1981;127:1232-1238
7. Ikehara S, Good RA, Nakamura T, Sekita K, Inoue S, Maung Maung Oo, Muso E, Ogawa K, Hamashima Y: Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci USA 1985; 82:2483-2487.
8. Ikehara S, Ohtsuki H, Good RA, Asamoto H, Nakamura T, Sekita K, Muso E, Tochino Y, Ida T, Kuzuya H, Imura H, Hamashima Y: Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1985;82: 7743-7747.
9. Yasumizu R, Sugiura K, Iwai H, Inaba M, Makino S, Ida T, Imura H, Hamashima Y, Good RA, Ikehara S: Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proc Natl Acad Sci USA 1987;84:6555-6557.
10. Oyaizu N, Yasumizu R, Inaba-Miyama M, Nomura S, Yoshida H, Miyawaki S, Shibata Y, Mitsuoka S, Yasunaga K, Morii S, Good RA, Ikehara S: (NZW x BXSB)F1 mouse, a new model of idiopathic thrombocytopenic purpura. J Exp Med 1988;167:2017-2022.
11. Ikehara S, Yasumizu R, Inaba M, Izui S, Hayakawa K, Sekita K, Toki J, Sugiura K, Iwai H, Nakamura T, Muso E, Hamashima Y, Good RA: Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1989;86:3306-3310.
12. Ikehara S, Kawamura M, Takao F, Inaba M, Yasumizu R, Soe Than, Hisha H, Sugiura K, Koide Y, Yoshida TO, Ida T, Imura H, Good RA: Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990;87: 8341-8344.
13. Van Bekkum DW, Bohre EPM, Houben PFJ, Knaan-Shanzer S: Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci USA 1989; 86:10090-10094.
14. Knaan-Shanzer S, Houben P, Kinwel-Bohre EPM, Van Bekkum DW: Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991;8: 333-338.
15. Karussis DM, Slavin S, Lehman D, Mizrachi-Kol R, Abramsky O, Ben-Nun A: Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol 1992;148: 1693-1698.
16. Van Gelder M, Kinwel-Bohré EPM, Van Bekkum DW: Treatment of experimental allergic encephalomyelitis with bone marrow transplantation. Exp Hematol 1993;21:1155.
17. Euler HH, Marmont AM, Bacigalupo A, Fastenrath S, Dreger P, Hoffknecht M, Zander AR, Schalke B, Hahn U, Haas R, Schmitz N: Early recurrence of persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996;88:3621-3625.
18. Nelson JL, Torrez R, Louie FM, Choe OS, Storb R, Sullivan KM: Pre-existing autoimmune diseases in patients with longterm survival after allogeneic bone marrow transplantation. J Rheumatol 1997;24:23-29.
19. Miyama-Inaba M, Kuma S, Inaba K, Ogata H, Iwai H, Yasumizu R, Muramatsu S, Steinman RM, Ikehara S: Unusual phenotype of B cells in the thymus of normal mice. J Exp Med 1988; 168:811-816.
20. Good RA, Martinez C, Gabrielsen AE: Clinical considerations of the thymus in immunobiology; in Good RA, Gabrielsen AE (eds): The Thymus in Immunobiology. New York, Hoeber-Harper, 1964, pp 3-48.
21. Mackay IR, Gail P: Thymic germinal centres and plasma cells in systemic lupus erythematosus. Lancet 1963;ii:667.
22. Ikehara S, Tanaka H, Nakamura T, Furukawa F, Inoue S, Sekita K, Shimizu J, Hamashima Y, Good RA: The influence of thymic abnormalities on the development of autoimmune diseases. Thymus 1985;7:25-36.
23. Nakamura T, Ikehara S, Good RA, Inoue S, Sekita K, Furukawa F, Tanaka H, Maung Maung Oo, Hamashima Y: Abnormal stem cells in autoimmune-prone mice are responsible for premature thymic involution. Thymus 1985;7:151-160.
24. Adachi Y, Inaba M, Inaba K, Soe Than, Kobayashi Y, Ikehara S: Analyses of thymic abnormalities in autoimmune-prone (NZW x BXSB)F1 mice. Immunobiology 1993; 188: 340-354.
25. Nakamura T, Good RA, Inoue S, Maung Maung Oo, Hamashima Y, Ikehara S: Successful liver allografts in mice by combination with allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1986;83:4529-4532.
26. Hang LM, Izui S, Dixo FJ: (NZW x BXSB F1) hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction. J Exp Med 1981;154:216-221.
27. Adachi Y, Inaba M, Amoh Y, Yoshifusa H, Nakamura Y, Suzuki H, Akamatu S, Nakai S, Haruna H, Adachi M, Ikehara S: Effect of bone marrow transplantation on anti-phospholipid antibody syndrome in murine lupus mice. Immunobiology 1995;192:218-230
28. Nishioka N, Toki J, Cherry, Sugiura K, Soe Than, Yasumizu R, Inaba M, Nishimura M, Ikehara S: Repair mechanism of lupus nephritis in (NZB x NZW)F1 mice by allogeneic bone marrow transplantation. Immunobiology 1995;192:279-296.
29. Estess P, Begovich AB, Koo M, Jones PP, McDevitt HO: Sequence analysis and structure function of murine q, k, u, s, and f haplotype I-Aβ cDNA clones. Proc Natl Acad Sci USA 1986;83:3594-3598.
30. Koide Y, Yoshida TO: The unique nucleotide sequence of the Ab gene in the NOD mouse is shared with its nondiabetic sister strains, the ILI and the CTS mouse. Int Immunol 1989;2: 189-192.
31. Nishimoto H, Kikutani H, Yamamura K, Kishimoto T: Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 1989;328:432-434.
32. Reich EP, Sherwin RS, Kanagawa O, Janeway CA Jr: An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature 1989;341:326-328.
33. Acha-Orbea H, McDevitt HO: The first external domain of the nonobese diabetic mouse class II I-Aβ chain is unique. Proc Natl Acad Sci USA 1987;84:2435-2439.
34. Todd JA, Bell JI, McDevill HO: HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987;329:599-604.
35. Visser JWM, Bauman JGJ, Mulder AH, Eliason JF, de Leeuw AM: Isolation of murine pluripotent hemopoietic stem cells. J Exp Med 1984;159:1576-1590.
36. Miyama-Inaba M, Ogata H, Toki J, Kuma S, Sugiura K, Yasumizu R, Ikehara S: Isolation of murine pluripotent hemopoietic stem cells in the Go phase. Biochem Biophys Res Commun 1987;75:1809-1812.
37. Ogata H, Bradley WG, Inaba M, Ogata N, Ikehara S, Good RA: Long-term repopulation of hematolymphoid cells with only a few hemopoietic stem cells in mice. Proc Natl Acad Sci USA 1995;92:5945-5949.
38. Katayama N, Shih JP, Nishikawa S, Kinaa T, Clark SC, Ogawa M: Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood 1993;82:2353-2360.
39. Okada S, Nakauchi H, Nagayoshi K, Nishikawa S, Nishikawa S-I, Miura Y, Suda T: Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 1991;78:1706-1712.
40. Sugiura K, Inaba M, Ogata H, Yasumizu R, Inaba K, Good RA, Ikehara S: Wheat germ agglutinin-positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity. Proc Natl Acad Sci USA 1988;85:4824-4826.
41. Sugiura K, Ikehara S, Inaba M, Haraguchi S, Ogata H, Sardiña EE, Sugawara M, Ohta Y, Good RA: Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen. Exp Hematol 1992;20:256-263.
42. Izumi-Hisha H, Soe Than, Ogata H, Inaba M, Ikehara S, Kawai M: Monoclonal antibodies against a preadipose cell line (MC3T3-G2/ PA6) which can support hemopoiesis. Hybridoma 1992;10:103-112.
43. Cherry, Yasumizu R, Toki J, Asou H, Nishino T, Komatsu Y, Ikehara S: Production of hemopoietic stem cell-chemotactic factor by bone marrow stromal cells. Blood 1994;83:964-971.
44. Ishida T, Inaba M, Hisha H, Sugiura K, Adachi Y, Nagata N, Ogawa R, Good RA, Ikehara S: Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation: Complete prevention of recurrence of autoimmune diseases in MRL/ MP-1pr/lpr mice by transplantation of bone marrow plus bone (stromal cells) from the same donor. J Immunol 1994;152:3119-3127.
45. Hisha H, Nishino T, Kawamura M, Adachi S, Ikehara S: Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol 1995;23:347-352.
46. Hashimoto F, Sugiura K, Inoue K, Ikehara S: Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 1997;89:49-54.
47. Lichtman MA: Classification and clinical manifestations of the hemopoietic stem cell disorders; in Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds): Hematology. Hemopoietic Stem Cell Disorders: Classification and Manifestations. New York, McGraw-Hill, 1990, pp 148-157.
48. Shimizu J, Hamashima Y, Tsuda H, Akiyama Y, Mikawa H, Ikehara S: A case report: T-cell acute lymphoblastic leukemia relapsing as acute myelomonocytic leukemia and terminating possibly as chronic myelocytic leukemia. Am J Hematol 1987;24:199-205.
49. Kawamura M, Hisha H, Li Y, Fukuhara S, Ikehara S: Distinct qualitative differences between normal and abnormal hemopoietic stem cells in vivo and in vitro. Stem Cells 1997;15:56-62.
50. Baldwin JL, Storb R, Thomas ED, Mannik M: Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977;20:1043-1048.
51. Jacobs P, Vincent MD, Martell RW: Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anemia. Bone Marrow Transplant 1986;1;237-239.
52. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC: Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 1993;20:137-140.
53. Eedy DJ, Burrows D, Bridges JM, Jones FG: Clearance of severe psoriasis after allogeneic bone marrow transplantation. Br Med J 1990; 300:908-909.
54. Liu Yin JA, Jowitt SN: Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1992;9:31-33.
55. Grau JM, Casademont J, Monforte R, Marin P, Grañena A, Rozman C, Urbano-Marquez A: Myasthenia gravis after allogeneic bone marrow transplantation: Report of a new case and pathogenetic considerations. Bone Marrow Transplant 1990;5:435-437.
56. Melms A, Faul C, Sommer N, Wietholter H, Muller CA, Ehninger G: Myasthenia gravis after BMT: Identification of patients at risk? Bone Marrow Transplant 1992;9:78-79.
57. Wyatt DT, Lum L, Casper J, Hunter J, Camitta B: Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transplant 1990;5:357-361.
58. Aldouri MA, Ruggier R, Epstein O, Prentice HG: Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia. Br J Haematol 1990;74:118-119.
59. Hagopian W, Lernmark A: Autoimmune diabetes mellitus; in Rose NR, Mackay IR (eds): The Autoimmune Diseases II. San Diego, Academic Press, 1992, pp 235-278.
60. Lampeter EF, Homberg M, Quabeck K, Schaffer UW, Wernet P, Bertrams J, Grosse-Wilde H, Gries FA, Kolb H: Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 1993;341:1243-1244.
61. Vialettes B, Maraninchi D, San Marco MP, Birg F, Stoppa AM, Mattei-Zevaco C, Thivolet C, Hermitte L, Vague P, Mercier P: Autoimmune polyendocrine failure - Type I (insulin-dependent) diabetes mellitus and hypothyroidism - after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia. Diabetologia 1993;36:541-546.
62. Lampeter EB: Discussion remark to Session 24: BMT in autoimmune diseases. Exp Hematol 1993;21:1153-1156.
63. Holland FJ, McConnon JK, Volpé R, Saunders EF: Concordant Graves' disease after bone marrow transplantation: Implication for pathogenesis. J Clin Endocrinol Metab 1991;72:837-840.
64. Marmont AM: Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases? Stem Cell 1994;12:125-135.
65. Sullivan KM, Furst DE (eds): Role of hematopoietic stem cell transplantation for autoimmune diseases, Fred Hutchinson Cancer Research Center, Seattle, October 27, 1995. J Rheumatol 1997;24(suppl 48):1-102.
66. Hosaka N, Nose M, Kyogoku M, Nagata N, Miyashima S, Good RA, Ikehara S: Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+ mice. Proc Natl Acad Sci USA 1996;93:8558-8562.